Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

-Ahead of print
-Authors' Accepted
    Manuscripts
new!
-Current Issue
-Archive
-Acknowledgments
-Special Issues
-Browse by Category

Manuscript Submission

-Online Submission
-Online Review
-Instruction for Authors
-Instruction for Reviewers
-English Corner new!

About AJA

-About AJA
-Editorial Board
-Contact Us
-News

Resources & Services

-Advertisement
-Subscription
-Email alert
-Proceedings
-Reprints

Download area

-Copyright licence
-EndNote style file
-Manuscript word template
-Guidance for AJA figures
    preparation (in English)

-Guidance for AJA figures
    preparation (in Chinese)

-Proof-reading for the
    authors

-AJA Club (in English)
-AJA Club (in Chinese)

 
Browse by Category

  Research Highlight from:
  2023 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |

2014 Research Highlight


Tools to identify the men with prostate cancer most appropriate for active surveillance?
Robert H Getzenberg
Asian J Androl : 97-98; 10.4103/1008-682X.122369
Abstract |Full Text | PDF [3042]


More evidence intratumoral DHT synthesis drives castration-resistant prostate cancer
Elizabeth M. Wilson
Asian J Androl : 99-100; 10.4103/1008-682X.122200
Abstract |Full Text | PDF [2953]


The multiple actions of testosterone in men: nature knows best
John W. Funder
Asian J Androl : 266-267; 10.4103/1008-682X.122367
Abstract |Full Text | PDF [2792]| 中文摘要


Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
Richard G. Pestell1, Zuoren Yu2
Asian J Androl : 268-269; 10.4103/1008-682X.122364
Abstract |Full Text | PDF [2568]| 中文摘要


Next generation patient-derived prostate cancer: xenograft models
Dong Lin1,2, Hui Xue1,2, Yuwei Wang1,2, Rebecca Wu1,2, Akira Watahiki1,2, Xin Dong2, Hongwei Cheng2, Alexander W. Wyatt1, Colin C. Collins1,3, Peter W. Gout2 and Yuzhuo Wang1,2,3
Asian J Androl : 407-412; 10.4103/1008-682X.125394
Full Text | PDF [2654]


Long-term survival of participants in the prostate cancer: prevention trial
Jonathan L Silberstein1, Oliver Sartor1,2
Asian J Androl : 413-414; 10.4103/1008-682X.122868
Full Text | PDF [2686]


Morbidity and psychological impact of prostate biopsy: the future calls for a change
Andrea Minervini, Gianni Vittori, Giampaolo Siena, Marco Carini
Asian J Androl : 415-417; 10.4103/1008-682X.126388
Full Text | PDF [2578]


Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
Gyorgy Petrovics, Shiv Srivastava
Asian J Androl : 418-419; 10.4103/1008-682X.126398
Full Text | PDF [2520]


Trading in your spindles for blebs: the amoeboid tumor cell phenotype in prostate cancer
Samantha Morley1, Martin H Hager2, Sara G Pollan3, Beatrice Knudsen3, Dolores Di Vizio1, Michael R Freeman4
Asian J Androl : 530-535; 10.4103/1008-682X.122877
Abstract |Full Text | PDF [2552]| 中文摘要


Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification
Yan Ting Chiang, Peter W Gout, Colin C Collins, Yuzhuo Wang
Asian J Androl : 545-548; 10.4103/1008-682X.122875
Abstract |Full Text | PDF [2505]| 中文摘要


Androgen receptor functions in prostate cancer development and progression
Steven P Balk
Asian J Androl : 561-564; 10.4103/1008-682X.126396
Abstract |Full Text | PDF [2552]| 中文摘要


Looking down on sperm motion: a useful added dimension?
Trevor G Cooper
Asian J Androl : 567-567; 10.4103/1008-682X.129135
Full Text | PDF [2608]


Exploring the role of anti‑angiogenic therapies in prostate cancer: results from the phase 3 trial of sunitinib
Himisha Beltran, Gurveen Kaur, Carmen Garcías de España, Scott T Tagawa
Asian J Androl : 568-569; 10.4103/1008-682X.127822
Full Text | PDF [2568]


Management of localized prostate cancer: the pendulum swings (back to the middle)
Winston Vuong1, Oliver Sartor2, Sumanta K Pal1
Asian J Androl : 570-571; 10.4103/1008-682X.131072
Full Text | PDF [2615]


Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation
John Lai1,2, Jyotsna Batra1,2
Asian J Androl : 659-660; doi: 10.4103/1008-682X.133323
Full Text | PDF [2170]


Lipogenic metabolism: a viable target for prostate cancer treatment?
Mengmeng Liang, David J Mulholland
Asian J Androl : 661-663; 10.4103/1008-682X.132947
Full Text | PDF [2925]


Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
Luca Incrocci
Asian J Androl : 664-665; 10.4103/1008-682X.133324
Full Text | PDF [3072]


Reappraisal of glucocorticoids in castrate-resistant prostate cancer
Oliver Sartor1, Christopher C Parker2, Johann de Bono2
Asian J Androl : 666-666; doi: 10.4103/1008-682X.133314
Full Text | PDF [2990]


Which one is the real matchmaker for the pair?
Chunsheng Han
Asian J Androl : 667-668; 10.4103/1008-682X.133316
Full Text | PDF [2953]


Regulation of cell adhesion in the testis: a new role for p73
Helen E. Abud1, Gary R. Hime2
Asian J Androl : 799-800; 10.4103/1008-682X.133315
Abstract |Full Text | PDF [2052]


Unraveling the intricacies of mammalian fertilization
Satish K Gupta
Asian J Androl : 801-802; doi: 10.4103/1008-682X.133325
Abstract |Full Text | PDF [2085]


Further analysis of PREVAIL: Enzalutamide use in chemotherapy-naïve men with metastatic castration-resistant prostate cancer
Jeanny B Aragon-Ching
Asian J Androl : 803-804; 10.4103/1008-682X.135129
Abstract |Full Text | PDF [1955]


Prevention of erectile dysfunction after radiotherapy for prostate cancer
Izak Faiena1, Neal Patel1, Allen D. Seftel2
Asian J Androl : 805-806; 10.4103/1008-682X.133327
Abstract |Full Text | PDF [2031]


Enzalutamide in chemo-naïve CRPC: effective for most but not for all
Benjamin L Maughan, Emmanuel S Antonarakis
Asian J Androl : 807-808; 10.4103/1008-682X.137680
Abstract |Full Text | PDF [2047]

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.